Graft rejection occurring in post–liver transplant patients receiving cytotoxic chemotherapy: A case series
Hui‐Hui Tan, M. Isabel Fiel, Juan del Rio Martin, Thomas D. Schiano – 28 May 2009 – Liver transplant recipients are known to be at increased risk for the development of de novo neoplasms or the recurrence of preexisting malignancies, and this is possibly related to the use of immunosuppressive medication. Little is known about the effects of cytotoxic chemotherapy on graft function after transplantation. A retrospective chart and pathology database review was undertaken to identify post–liver transplant patients developing rejection during chemotherapy.